I want
to...

Urgent
Care

Coronavirus (COVID-19) Advisory: Please help us limit exposure. Learn more about COVID-19 and where to go if you have concerns.

Clinic Hours Update: Select primary care and specialty clinics have adjusted clinic hours or are temporarily closed. Visit our locations page and call your provider’s office to confirm availability and address. Alternatively, you can schedule a telehealth visit. Learn more.

Basket Study at St. Joseph Health Medical Group

St. Joseph Health Medical Group is currently enrolling patients for the following basket studies:

A Phase 1/2 Study of Galinpepimut-S in Combination with Pembrolizumab (MK-3475) in Patients with Selected Advanced Cancers (SELLAS)

Treatment agent: Galinpepimut-S (WT1 immunotx) + pembro
PI: Jarrod Holmes, MD
Study Coordinator: Sabine Ucik // Sabine.Ucik@stjoe.org // (707) 521-3830
Resources and Links: clinicaltrials.gov NCT No: NCT03761914

Mon - Fri: CLOSED Sat - Sun: 9 a.m. - 2 p.m. (Last walk-in patient at 1:30 p.m.)

Basket Study at St. Joseph Health Medical Group

A Phase 1/2 Study of Galinpepimut-S in Combination with Pembrolizumab (MK-3475) in Patients with Selected Advanced Cancers (SELLAS)

Mon - Fri: CLOSED
Sat - Sun: 9 a.m. - 2 p.m. (Last walk-in patient at 1:30 p.m.)